Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 13, Issue 5, 2010, Pages 541-547

  Zhou, Xin ^a,b   Fragala, Maren S ^a   McElhaney, Janet E ^a,b   Kuchel, George A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

ELISA; multiplex; sample collection; sample handling

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FOOD INTAKE; GOLD STANDARD; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFLAMMATION; MEASUREMENT; MEDIATOR RELEASE; PHYSICAL ACTIVITY; REVIEW; STRESS; TECHNOLOGY; TISSUE INJURY;

BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 77955924626     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32833cf3bc     Document Type: Review

References (50)

1. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell 2010;140:771-776.
2. Mak TW, Saunders ME. Cytokines and cytokine receptors. In The immune response. Basic and clinical principals. San Diego: Elsevier Academic Press; 2006. pp. 464-516.
3. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140:871-882.
4. Maggio M, Guralnik JM, Longo DL, Ferrucci L Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol A Biol Sci Med Sci 2006; 61:575-584.
5. Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 2006; 54:991-1001.
6. Leng SX, McElhaney JE, Walston JD, et al. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol Ser A Biol Sci Med Sci 2008; 63:879-884.
7. Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol 2003; 111:S460-S475.
8. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol 2005; 175:5-14.
9. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532.
10. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28:454-467.
11. Gaffen SL Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009; 9:556-567.
12. Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106:255-258.
13. Thelen M, Stein JV. How chemokines invite leukocytes to dance. Nat Immunol 2008; 9:953-959.
14. Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF-and IL-2 receptors in healthy volunteers. Brain Behav Immun 2004; 18:361-367.
15. Vgontzas AN, Bixler EO, Lin HM, et al. IL-6 and its circadian secretion in humans. Neuroimmunomodulation 2005; 12:131-140.
16. Scheff JD, Calvano SE, Lowry SF, Androulakis IP. Modeling the influence of circadian rhythms on the acute inflammatory response. J Theor Biol 2010; 264:1068-1076.
17. Petrovsky N, McNair P, Harrison LC. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 1998; 10:307-312.
18. Dai G, McMurray DN. Altered cytokine production and impaired antimyco-bacterial immunity in protein-malnourished guinea pigs. Infect Immun 1998; 66:3562-3568.
19. Grimble RF, Tappia PS. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. Z Ernahrungswiss 1998; 37 (Suppl 1): 57-65.
20. Dandona P, Weinstock R, Thusu K, et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998; 83:2907-2910.
21. Blackburn P, Despres JP, Lamarche B, et al. Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) 2006; 14:1747-1754.
22. Payette C, Blackburn P, Lamarche B, et al. Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 2009; 58:1593-1601.
23. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106:2067-2072.
24. Carroll MF, Schade DS. Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003; 108: 24-31.
25. Ostrowski K, Rohde T, Zacho M, et al. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol 1998; 508:949-953.
26. Steensberg A, Keller C, Starkie RL, et al. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002; 283:E1272-E1278.
27. Gabriel H, Kindermann W. The acute immune response to exercise: what does it mean? Int J Sports Med 1997; 18 (Suppl 1):S28-S45.
28. Nieman DC, Pedersen BK. Exercise and immune function. Recent developments. Sports Med 1999; 27:73-80.
29. Ostrowski K, Rohde T, Asp S, et al. Pro-and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol 1999; 515 (Pt 1):287-291.
30. Seiler W, Muller H, Hiemke C. Interleukin-6 in plasma collected with an indwelling cannula reflects local, not systemic, concentrations. Clin Chem 1994; 40:1778-1779.
31. Lum G, Gambino SR. A comparison of serum versus heparinized plasma for routine chemistry tests. Am J Clin Pathol 1974; 61:108-113.
32. Riches P, Gooding R, Millar BC, Rowbottom AW. Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods 1992; 153:125-131.
33. Cannon JG, Van der Meer JW, Kwiatkowski D, et al. Interleukin-1 beta in human plasma: optimization of blood collection, plasma extraction, and radio-immunoassay methods. Lymphokine Res 1988; 7:457-467.
34. Thavasu PW, Longhurst S, Joel SP, et al. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 1992; 153:115-124.
35. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 2000; 12:1712-1716.
36. Engelberts I, Moller A, Schoen GJ, et al. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991; 10:69-76.
37. Banks RE. Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. Crit Rev Clin Lab Sci 2000; 37:131-182.
38. Bienvenu JA, MonneretG,Gutowski MC, Fabien N. Cytokine assays in human sera and tissues. Toxicology 1998; 129:55-61.
39. PanickerG, Meadows KS, LeeDR, etal. Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine 2007; 37:176-179.
40. De Jager W, Bourcier K, Rijkers GT, etal. Prerequisites for cytokine measure-ments in clinical trials with multiplex immunoassays. BMC Immunol 2009; 10:52.
41. Stefura WP, Campbell JD, Douville R, etal. Ultrasensitive ELISA for measurement of human cytokine responses in primary culture. Methods Mol Med 2008; 138:107-119.
42. Aziz N, Nishanian P, Mitsuyasu R, et al. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999; 6:89-95.
43. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006; 38:317-323.
44. Khan SS, Smith MS, RedaD, etal. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 2004; 61:35-39.
45. Chowdhury F, Williams A, Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 2009; 340:55-64.
46. Richens JL, Urbanowicz RA, Metcalf R, et al. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 2010.
47. Khan IH, Krishnan VV, Ziman M, et al. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B Clin Cytom 2009; 76:159-168.
48. Prabhakar U, Eirikis E, Reddy M, et al. Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants. J Immunol Methods 2004; 291:27-38.
49. McLaughlin BE, Baumgarth N, Bigos M, et al. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: panel design by an empiric approach. Cytometry A 2008; 73:400-410.
50. McLaughlin BE, Baumgarth N, Bigos M, et al. Nine-color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: panel performance across different instrument platforms. Cytometry A 2008; 73:411-420.